Core Laboratories N.V. Company Profile (NYSE:CLB)

About Core Laboratories N.V.

Core Laboratories N.V. logoCore Laboratories N.V. is a provider of reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company's services and products are directed toward enabling the Company's clients to improve reservoir performance and increase oil and gas recovery from their producing fields. The Company has over 70 offices in over 50 countries. The Company operates in three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples. The Production Enhancement segment includes products and services relating to reservoir well completions, perforations, stimulations and production. The Reservoir Management segment combines and integrates information from reservoir description and production enhancement services to increase production and improve recovery of oil and gas from the Company's clients' reservoirs.

Industry, Sector and Symbol:
  • Sector: Oils/Energy
  • Industry: Oil & Gas Equipment & Services
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: CLB
  • CUSIP:
Key Metrics:
  • Previous Close: $114.12
  • 50 Day Moving Average: $120.26
  • 200 Day Moving Average: $113.47
  • 52-Week Range: $44,152,000.00 - $96.30
  • Trailing P/E Ratio: 78.16
  • Foreward P/E Ratio: 36.93
  • P/E Growth: 3.41
  • Market Cap: $5.04B
  • Outstanding Shares: 44,152,000
  • Beta: 1.55
  • Net Margins: 10.74%
  • Return on Equity: 65.65%
  • Return on Assets: 11.51%
  • Debt-to-Equity Ratio: 1.27%
  • Current Ratio: 1.98%
  • Quick Ratio: 1.58%
Additional Links:
Companies Related to Core Laboratories N.V.:

Analyst Ratings

Consensus Ratings for Core Laboratories N.V. (NYSE:CLB) (?)
Ratings Breakdown: 3 Sell Ratings, 6 Hold Ratings, 4 Buy Ratings
Consensus Rating:Hold (Score: 2.08)
Consensus Price Target: $123.83 (8.51% upside)

Analysts' Ratings History for Core Laboratories N.V. (NYSE:CLB)
DateFirmActionRatingPrice TargetDetails
12/7/2016StephensDowngradeEqual Weight -> Sell$91.00View Rating Details
12/6/2016GuggenheimDowngradeBuy -> NeutralView Rating Details
10/22/2016Cowen and CompanyReiterated RatingMarket Perform$105.00View Rating Details
10/11/2016Citigroup Inc.Boost Price TargetNeutral$110.00 -> $115.00View Rating Details
10/5/2016DA DavidsonInitiated CoverageBuy$136.00View Rating Details
9/30/2016Loop CapitalInitiated CoverageHold$120.00View Rating Details
9/1/2016Credit Suisse GroupInitiated CoverageNeutral$115.00View Rating Details
7/12/2016J P Morgan Chase & CoDowngradeNeutral -> UnderweightView Rating Details
6/13/2016KLR GroupReiterated RatingBuy$166.00 -> $180.00View Rating Details
4/23/2016Royal Bank Of CanadaReiterated RatingBuyView Rating Details
4/23/2016SimmonsReiterated RatingHold$105.00 -> $115.00View Rating Details
4/22/2016ABN AmroDowngradeBuy -> SellView Rating Details
4/19/2016Morgan StanleyBoost Price TargetOverweight$120.00 -> $140.00View Rating Details
3/28/2016Howard WeilBoost Price Target$112.00View Rating Details
2/10/2016ING GroupLower Price TargetHold$125.00 -> $112.00View Rating Details
2/2/2016William BlairReiterated RatingOutperformView Rating Details
1/30/2016ScotiabankReiterated RatingSector Perform$117.00 -> $105.00View Rating Details
1/29/2016SunTrust Banks, Inc.Lower Price TargetBuy$123.00 -> $109.00View Rating Details
1/29/2016Iberia CapitalLower Price TargetOutperform$140.00 -> $115.00View Rating Details
1/26/2016HSBC Holdings plcDowngradeHold -> ReduceView Rating Details
1/11/2016Oppenheimer Holdings, Inc.Initiated CoverageMarket PerformView Rating Details
9/30/2015Sterne Agee CRTLower Price TargetNeutral$113.00 -> $108.00View Rating Details
(Data available from 2/19/2015 forward)


Earnings History for Core Laboratories N.V. (NYSE:CLB)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/25/201712/31/2016$0.41$0.41$145.78 million$149.54 millionViewN/AView Earnings Details
10/19/2016Q316$0.38$0.38$155.72 million$143.50 millionViewN/AView Earnings Details
7/20/2016Q216$0.35$0.35$146.37 million$148.10 millionViewN/AView Earnings Details
4/20/2016Q116$0.37$0.37$161.24 million$153.65 millionViewN/AView Earnings Details
1/27/2016Q415$0.65$0.65$179.48 million$182.70 millionViewListenView Earnings Details
10/21/2015Q315$0.83$0.83$203.29 million$197.27 millionViewListenView Earnings Details
7/22/2015Q215$0.77$0.82$195.13 million$204.00 millionViewListenView Earnings Details
4/22/2015Q115$0.85$0.86$211.82 million$213.64 millionViewN/AView Earnings Details
1/28/2015Q414$1.54$1.54$280.18 million$278.60 millionViewN/AView Earnings Details
10/22/2014Q314$1.51$1.53$284.30 million$276.14 millionViewListenView Earnings Details
7/23/2014Q214$1.34$1.35$269.70 million$267.56 millionViewListenView Earnings Details
4/23/2014Q114$1.45$1.35$283.02 million$262.90 millionViewListenView Earnings Details
1/30/2014Q413$1.40$1.43$278.55 million$276.30 millionViewListenView Earnings Details
10/17/2013Q313$1.34$1.36$267.21 million$273.16 millionViewN/AView Earnings Details
7/17/2013Q2 2013$1.31$1.32$267.24 million$263.14 millionViewListenView Earnings Details
4/17/2013Q1 2013$1.15$1.22$260.90 million$260.90 millionViewListenView Earnings Details
1/30/2013Q4 2012$1.13$1.17$246.49 million$254.46 millionViewListenView Earnings Details
10/17/2012$1.10$1.13ViewN/AView Earnings Details
7/18/2012$1.16$1.16ViewN/AView Earnings Details
4/18/2012$1.07$1.06ViewN/AView Earnings Details
2/1/2012$1.08$1.09ViewN/AView Earnings Details
10/19/2011$0.99$0.93ViewN/AView Earnings Details
4/19/2011$0.75$0.77ViewN/AView Earnings Details
2/9/2011$0.81$0.84ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Core Laboratories N.V. (NYSE:CLB)
Current Year EPS Consensus Estimate: $2.09 EPS
Next Year EPS Consensus Estimate: $3.09 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20166$0.35$0.75$0.53
Q2 20163$0.27$0.72$0.45
Q3 20164$0.28$0.77$0.46
Q4 20164$0.32$0.76$0.48
Q1 20173$0.39$0.81$0.54
Q2 20173$0.44$0.88$0.60
Q3 20173$0.48$0.97$0.69
Q4 20173$0.45$1.03$0.73
Q1 20181$0.73$0.73$0.73
Q2 20181$0.84$0.84$0.84
Q3 20181$1.00$1.00$1.00
Q4 20182$0.65$1.08$0.87
(Data provided by Zacks Investment Research)


Current Dividend Information for Core Laboratories N.V. (NYSE:CLB)
Annual Dividend:$2.20
Dividend Yield:1.93%
Dividend Growth:19.80% (3 Year Average)
Payout Ratio:150.68% (Based on Trailing 12 Months of Earnings)
105.26% (Based on Current Year Consensus EPS Estimate)
71.20% (Based on Next Year Consensus EPS Estimate)

Dividend History for Core Laboratories N.V. (NYSE:CLB)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Core Laboratories N.V. (NYSE:CLB)
Insider Ownership Percentage: 1.00%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/1/2017Michael StraughenDirectorBuy106$118.65$12,576.90View SEC Filing  
1/30/2017Martha Z CarnesDirectorBuy200$115.20$23,040.00View SEC Filing  
2/2/2016Jan Willem SodderlandDirectorBuy300$93.90$28,170.00View SEC Filing  
5/12/2015Michael C KearneyDirectorSell1,000$128.52$128,520.00View SEC Filing  
11/17/2014Mark F ElvigVPSell1,000$138.03$138,030.00View SEC Filing  
7/28/2014Richard L BergmarkCFOBuy7,000$147.31$1,031,170.00View SEC Filing  
3/7/2014Michael KearneyDirectorSell2,000$193.00$386,000.00View SEC Filing  
2/14/2014Mark ElvigVPSell1,500$186.64$279,960.00View SEC Filing  
10/21/2013Monty L DavisCOOSell5,704$197.33$1,125,570.32View SEC Filing  
8/7/2013Richard BergmarkCFOSell20,000$149.58$2,991,600.00View SEC Filing  
7/25/2013Charles Brigham MillerCAOSell11,648$147.81$1,721,690.88View SEC Filing  
7/25/2013Monty L DavisCOOSell5,948$149.12$886,965.76View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Core Laboratories N.V. (NYSE:CLB)
DateHeadline logoTop Stocks Poised to Bounce Back in 2017 (NYSE:CLB) - February 18 at 10:38 AM logoCORE LABORATORIES N V Financials (NYSE:CLB) - February 16 at 4:23 PM
News IconAnalysts Take the Wheel on Core Laboratories NV (NYSE:CLB) Shares and Where They Might Be Headed - Aiken Advocate (NYSE:CLB) - February 14 at 5:07 PM logoCORE LABORATORIES N V Files SEC form 10-K, Annual Report (NYSE:CLB) - February 10 at 4:35 PM logoShould Options Traders Watch OFS Stock Returns? (NYSE:CLB) - February 8 at 4:38 PM logoLand This Cheap Energy Stock Even Lower Than Director Straughen Did (NYSE:CLB) - February 6 at 4:22 PM logoETFs with exposure to Core Laboratories NV : February 6, 2017 (NYSE:CLB) - February 6 at 4:22 PM
News Icon5 Things Core Laboratories N.V.'s Management Wants You to Know About What's Actually Going On in the Oil Market - Fox Business (NYSE:CLB) - January 31 at 9:47 PM logo5 Top Stocks to Buy in 2017 (NYSE:CLB) - January 31 at 4:45 PM logoThe oil reservoir specialist listens to what the oil fields are saying about supplies. (NYSE:CLB) - January 30 at 10:11 PM logoCLB Makes Notable Cross Below Critical Moving Average (NYSE:CLB) - January 30 at 5:10 PM logoCore Laboratories (CLB) Q4 Earnings in Line, Revenues Top (NYSE:CLB) - January 30 at 5:10 PM logoCore Laboratories NV breached its 50 day moving average in a Bearish Manner : CLB-US : January 30, 2017 (NYSE:CLB) - January 30 at 5:10 PM logoCore Laboratories Base Broadening (NYSE:CLB) - January 30 at 5:10 PM logoCore Laboratories NV :CLB-US: Earnings Analysis: 2016 By the Numbers : January 27, 2017 (NYSE:CLB) - January 27 at 5:44 PM logoEdited Transcript of CLB earnings conference call or presentation 26-Jan-17 1:30pm GMT (NYSE:CLB) - January 26 at 10:20 PM logoEPS Forecast Of Core Laboratories NV (NYSE:CLB) Set At $0.6075 - Investor Newswire (NYSE:CLB) - January 26 at 5:19 PM logoCore Laboratories' (CLB) CEO David Demshur on Q4 2016 Results - Earnings Call Transcript - Seeking Alpha (NYSE:CLB) - January 26 at 5:19 PM logoAnalysts’ Forecasts for NOV before Its 4Q16 Earnings (NYSE:CLB) - January 26 at 5:19 PM logoThe Highly Anticipated Earnings Recovery at Core Laboratories N.V. Finally Takes Hold (NYSE:CLB) - January 26 at 8:52 AM
News IconCore Laboratories N.V. (NYSE:CLB) to Post $0.41 Earnings Per Share: Analysts - Wall Street Beacon (NYSE:CLB) - January 26 at 3:29 AM logoExclusive: Millions of barrels of Venezuelan oil stuck at sea in dirty tankers (NYSE:CLB) - January 26 at 3:29 AM logoCore Laboratories N : Lab Reports Forth-Quarter 2016 Results (NYSE:CLB) - January 25 at 10:27 PM logoCore Laboratories meets 4Q profit forecasts (NYSE:CLB) - January 25 at 10:27 PM logoQ4 2016 Core Laboratories NV Earnings Release - After Market Close (NYSE:CLB) - January 25 at 5:25 PM logoCORE LABORATORIES N V Files SEC form 8-K, Results of Operations and Financial Condition (NYSE:CLB) - January 25 at 5:25 PM logoCore Lab Reports Fourth Quarter 2016 Results: (NYSE:CLB) - January 25 at 5:25 PM logoOil Stock Q4 Earnings to Watch on Jan 25: CLB, RES, FTK (NYSE:CLB) - January 24 at 4:54 PM logoWhy Earnings Season Could Be Great for Core Laboratories (CLB) (NYSE:CLB) - January 24 at 4:54 PM logoGet Excited About These 5 Big Short Squeezes (NYSE:CLB) - January 24 at 4:54 PM logo3 Key Metrics Core Laboratories N.V. Investors Should Focus On This Week (NYSE:CLB) - January 23 at 10:25 AM logoCore Laboratories NV (NYSE:CLB) EPS Target Set For $0.6075 - Investor Newswire (NYSE:CLB) - January 21 at 9:24 PM logoCore Laboratories (CLB) Q4 Earnings: Is a Beat in Store? (NYSE:CLB) - January 20 at 5:30 PM logoTaylor Wealth Management Partners Buys iShares Russell 2000, Eagle Materials Inc, First ... (NYSE:CLB) - January 19 at 5:33 PM logoWill Upstream Operators’ Capex Affect Flotek’s 4Q16 Margin? (NYSE:CLB) - January 19 at 5:33 PM logoWeatherford International: Why Short Interest in the Stock Rose (NYSE:CLB) - January 18 at 4:39 PM logoCORE LABORATORIES : ex-dividend day (NYSE:CLB) - January 17 at 10:09 PM logoCash Dividend On The Way From Core Laboratories (NYSE:CLB) - January 17 at 5:08 PM logoHow Have Superior Energy’s Recommendations Changed before the 4Q16 Earnings? (NYSE:CLB) - January 13 at 4:33 PM logoCore Lab Announces Q1 2017 Quarterly Dividend (NYSE:CLB) - January 10 at 5:01 PM logoCORE LABORATORIES N V Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NYSE:CLB) - January 10 at 5:01 PM logoCore Laboratories declares $0.55 dividend (NYSE:CLB) - January 10 at 4:27 PM logoCore Laboratories' Fourth Quarter 2016 Webcast At 7:30 A.M. CST / 2:30 P.M. CET On January 26, 2017 (NYSE:CLB) - January 5 at 9:54 PM logoCore Laboratories Reaches Analyst Target Price (NYSE:CLB) - January 5 at 4:53 PM logoETFs with exposure to Core Laboratories NV : December 30, 2016 (NYSE:CLB) - December 30 at 4:45 PM logoCore Laboratories N.V. (NYSE:CLB) Strong Buy Recommendations At 4 - Investor Newswire (NYSE:CLB) - December 29 at 4:42 PM logoWorst Oilfield Service Stocks: Analyzing Implied Volatility (NYSE:CLB) - December 29 at 4:42 PM logoWhy 2017 Is the Year to Invest in Oil Stocks (NYSE:CLB) - December 27 at 4:36 PM logoAnalyzing OFS Stocks’ Returns and Implied Volatility (NYSE:CLB) - December 23 at 4:31 PM logoWhat Happened to Oil Prices in 2016? (NYSE:CLB) - December 18 at 4:22 PM


What is Core Laboratories N.V.'s stock symbol?

Core Laboratories N.V. trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."

How often does Core Laboratories N.V. pay dividends? What is the dividend yield for Core Laboratories N.V.?

Core Laboratories N.V. announced a quarterly dividend on Tuesday, January 10th. Investors of record on Friday, January 20th will be given a dividend of $0.55 per share on Friday, February 17th. This represents a $2.20 dividend on an annualized basis and a yield of 1.93%. The ex-dividend date of this dividend is Wednesday, January 18th.

Where is Core Laboratories N.V.'s stock going? Where will Core Laboratories N.V.'s stock price be in 2017?

13 brokers have issued 12-month target prices for Core Laboratories N.V.'s shares. Their predictions range from $91.00 to $180.00. On average, they expect Core Laboratories N.V.'s stock price to reach $123.83 in the next twelve months.

When will Core Laboratories N.V. announce their earnings?

Core Laboratories N.V. is scheduled to release their next quarterly earnings announcement on Tuesday, April, 18th 2017.

What are analysts saying about Core Laboratories N.V. stock?

Here are some recent quotes from research analysts about Core Laboratories N.V. stock:

  • According to Zacks Investment Research, "Core Laboratories' was able to meet the fourth-quarter 2016 earnings on the back of increased U.S. onshore oil production.We like Core Labs’ leadership position in the reservoir optimization niche, along with its global footprint and deep portfolio of proprietary products and services. Furthermore, CLB’s low asset intensive operations and limited capex needs allow it to generate substantial free cash flows. However,Core Labs’ revenues are largely dependent on the completion and stimulation of wells. As seen for the fourth quarter, well completions increased only 2% on a sequential quarterly basis. Hence, lesser number of new wells and delayed production can pose a threat to Core Labs earnings and revenues." (1/30/2017)

  • J P Morgan Chase & Co analysts commented, "have run too hard too fast" with 39 percent downside to December '16 target price."[W]e think expectations have run too hard with other NAM beta plays, and a re-rating could lead to underperformance in 2H16 relative to equipment peers," analyst Sean Meakim wrote in a note.On the industry front, the analyst said flagging oil prices could easily crush hopes that E&P inquiries in NAM translate to material incremental work in the second half (or even 2017).Even if activity levels improve in the second half, Meakim remains concerned that production declines may soften, resulting in a less constructive oil price environment yield than what is necessary to instigate the next upcycle.Related Link: Exxon And Chevron's New $37-Billion Project Is "Inflection Point" For Oil Market"We think investor focus this earnings season is on confirming a 2Q bottom, but with expectations already implying 2H improvement, we believe disappointment could bring a broader pullback in the stocks," Meakim highlighted.Meanwhile, Forum Energy shares have risen significantly since February on better expectations for normalized activity next cycle. That said, the company is still cautious on the outlook for second half.Further, the analyst sees the possibility for a retreat as expectations reset in the second half if oil prices struggle to move higher and rig counts remain volatile. "Admittedly some of the heat has come off the stock already (-14 percent off its June 7 high v. -8 percent OSX), but we see more room to run," (7/12/2016)

Who owns Core Laboratories N.V. stock?

Core Laboratories N.V.'s stock is owned by a number of of retail and institutional investors. Top institutional investors include Russell Investments Group Ltd. (1.87%), Franklin Resources Inc. (1.42%), State Street Corp (1.20%), Van ECK Associates Corp (1.05%), Champlain Investment Partners LLC (0.98%) and Congress Asset Management Co. MA (0.96%). Company insiders that own Core Laboratories N.V. stock include Jan Willem Sodderland, Martha Z Carnes, Michael C Kearney and Michael Straughen.

Who sold Core Laboratories N.V. stock? Who is selling Core Laboratories N.V. stock?

Core Laboratories N.V.'s stock was sold by a variety of institutional investors in the last quarter, including Bessemer Group Inc., Marshall Wace LLP, Fiera Capital Corp, Friedberg Investment Management, Janus Capital Management LLC, AQR Capital Management LLC, Columbia Wanger Asset Management LLC and Capital Guardian Trust Co..

Who bought Core Laboratories N.V. stock? Who is buying Core Laboratories N.V. stock?

Core Laboratories N.V.'s stock was purchased by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Congress Asset Management Co. MA, AKO Capital LLP, Baird Financial Group Inc., Asset Management One Co. Ltd., Van ECK Associates Corp, Franklin Resources Inc. and Precocity Capital LP. Company insiders that have bought Core Laboratories N.V. stock in the last two years include Jan Willem Sodderland, Martha Z Carnes and Michael Straughen.

How do I buy Core Laboratories N.V. stock?

Shares of Core Laboratories N.V. can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Core Laboratories N.V. stock cost?

One share of Core Laboratories N.V. stock can currently be purchased for approximately $114.12.

Core Laboratories N.V. (NYSE:CLB) Chart for Sunday, February, 19, 2017

Institutional Ownership Chart

Institutional Ownership by Quarter for Core Laboratories N.V. (NYSE:CLB)

Earnings History Chart

Earnings by Quarter for Core Laboratories N.V. (NYSE:CLB)

Dividend History Chart

Dividend Payments by Quarter for Core Laboratories N.V. (NYSE:CLB)

Last Updated on 2/19/2017 by Staff